| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/03/2005 | WO2005010154A2 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | WO2005010047A2 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 02/03/2005 | WO2005009992A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | WO2005009991A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 02/03/2005 | WO2005009468A1 Remedy for cartilage-related diseases |
| 02/03/2005 | WO2005009431A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 02/03/2005 | WO2005009331A2 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 02/03/2005 | WO2004096829A3 Novel method and intermediates for the preparation of 19-nor-steroids-17-halogen compounds |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050027013 LTA4 hydrolase inhibitors |
| 02/03/2005 | US20050027009 New derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/03/2005 | US20050026990 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders |
| 02/03/2005 | US20050026988 Cyclopenta'b! indole derivatives as spla inhibitors |
| 02/03/2005 | US20050026980 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases |
| 02/03/2005 | US20050026979 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 02/03/2005 | US20050026973 New heterocyclic oxime compounds |
| 02/03/2005 | US20050026967 Inhibitors of c-jun N terminal kinases (JNK) and other protein kinases |
| 02/03/2005 | US20050026965 Pharmaceutical uses and synthesis of nicotinanilide-N-oxides |
| 02/03/2005 | US20050026956 Carbinols for the treatment of neuropathic dysfunction |
| 02/03/2005 | US20050026942 Chemokine receptor binding heterocyclic compounds |
| 02/03/2005 | US20050026941 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 02/03/2005 | US20050026915 As melanin concentrating hormone (MCH)receptor antagonists, for prevention or treatment of obesity or eating disorders; (2E)-3-(4-chlorophenyl)-N-[2-(dimethylamino)quinolin-6-yl]prop-2-enamide |
| 02/03/2005 | US20050026908 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer |
| 02/03/2005 | US20050026905 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 02/03/2005 | US20050026904 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026870 Use of bisphosphonates for the treatment of osteogenesis imperfecta |
| 02/03/2005 | US20050026867 Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain |
| 02/03/2005 | US20050026841 Hab18g/cd147 its antagonist and application |
| 02/03/2005 | US20050026839 Conformationally constrained parathyroid hormone (pth) analogs |
| 02/03/2005 | US20050026837 Novel proteins and methods for producing the proteins |
| 02/03/2005 | US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders |
| 02/03/2005 | US20050025806 A silicone support of methylvinylsiloxane polymer including a fumed silca reinforcement filler; growth and/or reproduction-associated drug, derivative or analogue and carrier; each implant of insufficient size and/or payload for the predetermined threshold blood level of indicated drug; high-speed |
| 02/03/2005 | US20050025765 Antagonist is selected from an antioxidant or an inhibitor of a pro-inflammatory interleukin, TNF- alpha synthesis, membrane-bound TNF- alpha, a natural receptor of TNF- alpha, nitric oxide synthase, phospholipase A2, apoptosis, matrix metalloproteases, or p38 kinase |
| 02/03/2005 | US20050025751 Increased or reduced expression of tumor necrosis factors or interleukins; antiinflammatory agents; autoimmune diseases |
| 02/03/2005 | CA2770493A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | CA2534178A1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 02/03/2005 | CA2532102A1 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 02/03/2005 | CA2531912A1 Process for producing 1,2,4-triazole compound and intermediate therefor |
| 02/03/2005 | CA2528586A1 Cyclohexanecarboxylic acid compound |
| 02/02/2005 | EP1502600A1 Use of botulinum toxin for treating smooth muscle disorders |
| 02/02/2005 | EP1502593A1 The use of Stanozolol for the preparation of anti-inflammatory and anti-degenerative drugs |
| 02/02/2005 | EP1502590A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes |
| 02/02/2005 | EP1502586A1 Preparations for the application of anti-inflammatory agents |
| 02/02/2005 | EP1501919A1 Soya cell strains with high isoflavone content |
| 02/02/2005 | EP1501866A2 Apo-2 ligand variants and uses thereof |
| 02/02/2005 | EP1501834A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501833A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
| 02/02/2005 | EP1501819A1 Estrogen receptor modulators |
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 02/02/2005 | EP1501801A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501566A1 Medical products comprising a haemocompatible coating, production and use thereof |
| 02/02/2005 | EP1501565A1 Compounds and method for coating surfaces in a haemocompatible manner |
| 02/02/2005 | EP1501560A1 Surgical material comprising water soluble glass fibres |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501525A1 Method for producing preparations rich in tocotrienol |
| 02/02/2005 | EP1501523A1 Carbon monoxide as a biomarker and therapeutic agent |
| 02/02/2005 | EP1501515A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501512A2 4-azasteroid derivatives as androgen receptor modulators |
| 02/02/2005 | EP1501511A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1501505A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h- 1,2,4 -t riazole for the treatment of autoimmune diseases |
| 02/02/2005 | EP1501504A1 1-substituted imidazole derivatives as nos inhibitors |
| 02/02/2005 | EP1501491A2 Methods and compositions for treatment of cancer pain |
| 02/02/2005 | EP1501357A2 Use of vegf for treating bone defects |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1379257A4 Prodrugs of anticancer agents employing substituted aromatic acids |
| 02/02/2005 | EP1362050B1 Pyrimidine derivatives for inhibition of cell-proliferation |
| 02/02/2005 | EP1303506B1 6-heteroarylphenanthridines |
| 02/02/2005 | EP1161235B1 Combinations for the treatment of diseases involving angiogenesis |
| 02/02/2005 | EP1124779B1 Vitamin d analogues |
| 02/02/2005 | EP1025079B1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 02/02/2005 | EP0828754B1 Dipeptides which promote release of growth hormone |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1575290A Pyrimidine derivatives and pharmaceutical compositions containing that compounds |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575191A Treatment of insulin resistance syndrome and type 2 diabetes with PDE9 inhibitors |
| 02/02/2005 | CN1575184A Method and composition for treating immune complex associated disorders |
| 02/02/2005 | CN1575182A Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575174A Pharmaceutically active isoindoline derivatives |
| 02/02/2005 | CN1575173A Macrolides containing pharmaceutical compositions |
| 02/02/2005 | CN1575172A Substituted ideno[1, 2-c]isoquinoline derivatives and methods of use thereof |
| 02/02/2005 | CN1575167A Method for treatment of reactive arthritis or bursitis |
| 02/02/2005 | CN1572320A Method for erythropoietin administration using pharmacokinetic and pharmacodynamic modeling |
| 02/02/2005 | CN1572318A Composition containing dipeptide of histidine and alanine for reducing uric acid |
| 02/02/2005 | CN1572305A Medicine for treating early and medium ankylosing spondylitis |
| 02/02/2005 | CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187332C Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187080C Blood-activating cream |
| 02/02/2005 | CN1187060C Extracts of shark cartilage, its preparation method and usage |
| 02/02/2005 | CN1187043C Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |